RenovoRx, Inc. (RNXT)
1.67
+0.19
(+12.84%)
USD |
NASDAQ |
Aug 28, 16:00
1.70
+0.03
(+1.80%)
After-Hours: 20:00
RenovoRx Price to Book Value : 8.392 for Aug. 28, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| August 28, 2026 | 8.392 |
| August 27, 2026 | 7.438 |
| August 26, 2026 | 7.488 |
| August 25, 2026 | 7.136 |
| August 24, 2026 | 6.282 |
| August 21, 2026 | 6.634 |
| August 20, 2026 | 6.634 |
| August 19, 2026 | 6.608 |
| August 18, 2026 | 5.880 |
| August 17, 2026 | 6.030 |
| August 14, 2026 | 7.036 |
| August 13, 2026 | 6.332 |
| August 12, 2026 | 5.628 |
| August 11, 2026 | 5.779 |
| August 10, 2026 | 5.830 |
| August 07, 2026 | 5.628 |
| August 06, 2026 | 5.779 |
| August 05, 2026 | 5.327 |
| August 04, 2026 | 5.226 |
| August 03, 2026 | 5.327 |
| July 31, 2026 | 4.816 |
| July 30, 2026 | 4.730 |
| July 29, 2026 | 4.513 |
| July 28, 2026 | 4.560 |
| July 27, 2026 | 4.85 |
| Date | Value |
|---|---|
| July 24, 2026 | 4.348 |
| July 23, 2026 | 4.294 |
| July 22, 2026 | 4.350 |
| July 21, 2026 | 4.410 |
| July 20, 2026 | 4.340 |
| July 17, 2026 | 4.348 |
| July 16, 2026 | 4.427 |
| July 15, 2026 | 4.320 |
| July 14, 2026 | 4.272 |
| July 13, 2026 | 4.590 |
| July 10, 2026 | 4.674 |
| July 09, 2026 | 4.723 |
| July 08, 2026 | 4.523 |
| July 07, 2026 | 4.661 |
| July 06, 2026 | 4.762 |
| July 02, 2026 | 4.624 |
| July 01, 2026 | 4.800 |
| June 30, 2026 | 4.925 |
| June 29, 2026 | 3.879 |
| June 26, 2026 | 3.774 |
| June 25, 2026 | 3.719 |
| June 24, 2026 | 3.811 |
| June 23, 2026 | 3.642 |
| June 22, 2026 | 3.640 |
| June 18, 2026 | 3.679 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Enanta Pharmaceuticals, Inc. | 3.918 |
| Travere Therapeutics, Inc. | 252.20 |
| REGENXBIO, Inc. | 7.291 |
| Krystal Biotech, Inc. | 7.653 |
| ACADIA Pharmaceuticals, Inc. | 3.835 |
Price to Book Value Related Metrics
| PS Ratio | 33.51 |
| Price | 1.67 |
| Earnings Yield | -18.80% |
| Market Cap | 75.35M |